<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02520401</url>
  </required_header>
  <id_info>
    <org_study_id>s57668</org_study_id>
    <nct_id>NCT02520401</nct_id>
  </id_info>
  <brief_title>The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis</brief_title>
  <official_title>The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioGaia AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <brief_summary>
    <textblock>
      This studies aims to investigate the effect of a probiotics in peri-implantitis patients as
      an adjunct to non-surgical therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This studies aims to investigate the effect of a probiotics in peri-implantitis patients as
      an adjunct to non-surgical therapy.

      Study design: This study will be a single centre (Department of Oral Health Sciences,
      University Hospitals Leuven), double blind randomized, placebo controlled clinical trial. The
      randomization (by means of a computer program) and double blind design are thought to
      minimize the bias of the investigator and patients.

      Selection of the study population: Adults, who consult at the departement of Periodontology
      at the University Hospital Leuven, with peri-implantitis and who fit the inclusion criteria
      will be asked to participate in this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Probing Pocket Depth (PPD) at peri-implantitis sites</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Pocket probing depth measured with Merrit-B probe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding on Probing (BoP) at peri-implantitis sites</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Binairy outcome: 0: no bleeding, 1: bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque at peri-implantitis sites</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Binairy outcome: 0: no plaque, 1: plaque</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbial samples</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Of tongue coating, saliva and peri-implantitis site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full mouth plaque score (FMPS)</measure>
    <time_frame>Baseline - 6 months</time_frame>
    <description>Binairy outcome: 0: no plaque, 1: plaque</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Peri-implantitis</condition>
  <arm_group>
    <arm_group_label>Test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Probiotic tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probiotic - BioGaia</intervention_name>
    <description>Use of a probiotic tablet</description>
    <arm_group_label>Test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Use of a placebo tablet</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years of age

          -  Patients with at least one implant* diagnosed with initial peri-implantitis.

          -  Willing and able to give written informed consent

          -  No signs of acute periodontitis

          -  presence of keratinized tissue around treated implant(s)

        Exclusion Criteria:

          -  patients who smoke

          -  patients with periodontitis

          -  pregnant or lactating woman

          -  patients with poorly controlled diabetes

          -  patients taking bisphosphonate mediation

          -  patient who had taken systemic antibiotics 3 months prior to treatment

          -  peri-implantitis treatment 12 months prior intake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UZLeuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>May 6, 2015</study_first_submitted>
  <study_first_submitted_qc>August 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2015</study_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

